Elevance Health, Inc. (BMV:ELV)
Mexico · Delayed Price · Currency is MXN 6,550.00
+95.00 (1.47%)
At close: Oct 7, 2025
Elevance Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 5,349 | 5,971 | 5,991 | 5,888 | 6,149 | 4,572 | Upgrade |
Depreciation & Amortization | 1,480 | 1,393 | 1,745 | 1,675 | 1,302 | 1,154 | Upgrade |
Stock-Based Compensation | 199 | 191 | 289 | 264 | 255 | 283 | Upgrade |
Other Adjustments | 63 | -28 | 571 | 149 | -465 | -575 | Upgrade |
Change in Receivables | -3,439 | -683 | -1,762 | -2,510 | -2,138 | -256 | Upgrade |
Changes in Accounts Payable | 1,118 | -272 | 1,640 | 824 | 719 | 1,978 | Upgrade |
Changes in Income Taxes Payable | 833 | 404 | -103 | -338 | 140 | 72 | Upgrade |
Changes in Unearned Revenue | -140 | -113 | 290 | -42 | -113 | 202 | Upgrade |
Changes in Other Operating Activities | 810 | -1,055 | -600 | 2,489 | 2,515 | 3,257 | Upgrade |
Operating Cash Flow | 6,454 | 5,808 | 8,061 | 8,399 | 8,364 | 10,688 | Upgrade |
Operating Cash Flow Growth | 212.24% | -27.95% | -4.02% | 0.42% | -21.74% | 76.34% | Upgrade |
Capital Expenditures | -1,117 | -1,256 | -1,296 | -1,152 | -1,087 | -1,021 | Upgrade |
Purchases of Investments | -16,053 | -17,986 | -16,236 | -24,946 | -18,669 | -19,492 | Upgrade |
Proceeds from Sale of Investments | 18,383 | 18,572 | 13,536 | 22,608 | 14,613 | 16,059 | Upgrade |
Payments for Business Acquisitions | - | -4,809 | -1,552 | -649 | -3,476 | -1,976 | Upgrade |
Proceeds from Business Divestments | - | 363 | - | - | - | - | Upgrade |
Other Investing Activities | -169 | -51 | -24 | -421 | -1,019 | -894 | Upgrade |
Investing Cash Flow | -2,623 | -5,167 | -5,572 | -4,560 | -9,638 | -7,324 | Upgrade |
Short-Term Debt Issued | - | 275 | 225 | 1,365 | 1,375 | 970 | Upgrade |
Short-Term Debt Repaid | -135 | -135 | -265 | -1,675 | -1,050 | -1,820 | Upgrade |
Net Short-Term Debt Issued (Repaid) | -135 | 140 | -40 | -310 | 325 | -850 | Upgrade |
Long-Term Debt Issued | - | 7,710 | 2,574 | 3,071 | 3,462 | 2,484 | Upgrade |
Long-Term Debt Repaid | - | -1,650 | -1,909 | -1,899 | -1,068 | -1,932 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | 6,060 | 665 | 1,172 | 2,394 | 552 | Upgrade |
Issuance of Common Stock | 85 | 221 | 152 | 182 | 203 | 176 | Upgrade |
Repurchase of Common Stock | -3,129 | -2,900 | -2,676 | -2,316 | -1,900 | -2,700 | Upgrade |
Net Common Stock Issued (Repurchased) | -3,044 | -2,679 | -2,524 | -2,134 | -1,697 | -2,524 | Upgrade |
Common Dividends Paid | -1,522 | -1,508 | -1,395 | -1,229 | -1,104 | -954 | Upgrade |
Other Financing Activities | 477 | -820 | -55 | 1,183 | 505 | 1,209 | Upgrade |
Financing Cash Flow | -1,724 | 1,193 | -3,349 | -1,318 | 423 | -2,567 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1 | -6 | -1 | -14 | -10 | 7 | Upgrade |
Net Cash Flow | 2,108 | 1,828 | -861 | 2,507 | -861 | 804 | Upgrade |
Beginning Cash & Cash Equivalents | 6,497 | 6,526 | 7,387 | 4,880 | 5,741 | 4,937 | Upgrade |
Ending Cash & Cash Equivalents | 8,560 | -66 | 6,526 | 7,387 | 4,880 | 5,741 | Upgrade |
Free Cash Flow | 5,337 | 4,552 | 6,765 | 7,247 | 7,277 | 9,667 | Upgrade |
Free Cash Flow Growth | 17.24% | -32.71% | -6.65% | -0.41% | -24.72% | 93.96% | Upgrade |
FCF Margin | 2.84% | 2.60% | 3.97% | 4.66% | 5.31% | 8.00% | Upgrade |
Free Cash Flow Per Share | 23.28 | 19.54 | 28.50 | 29.85 | 29.49 | 38.01 | Upgrade |
Levered Free Cash Flow | 8,209 | 11,281 | 8,288 | 10,212 | 12,353 | 9,916 | Upgrade |
Unlevered Free Cash Flow | 8,336 | 4,602 | 7,589 | 9,279 | 8,950 | 10,039 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.